Supplemental methods

Liquid chromatrography -Mass Spectrometry based Metabolomics
Metabolites were extracted by adding 100 -200μl ice-cold MS lysis buffer (methanol/acetonitrile/uLCMS H2O (2:2:1)) to the cell pellets. To measure extracellular metabolites, metabolites were extracted by diluting 10μL medium in 1mL MS lysis buffer. Samples were shaken for 10 minutes at 4°C, centrifuged at 14.000g for 15 minutes at 4°C and supernatants were collected for LC-MS analysis. LC-MS analysis was performed on an Exactive mass spectrometer (Thermo Scientific) coupled to a Dionex Ultimate 3000 autosampler and pump (Thermo Scientific). The MS operated in polarity-switching mode with spray voltages of 4.5kV and -3.5kV. Metabolites were separated on a Sequant ZIC-pHILIC column (2.1 x 150mm, 5μm, Merck) with guard column (2.1 x 20mm, 5μm, Merck) using a linear gradient of acetonitrile and a buffer containing 20mM (NH4)2CO3, 0.1% NH4OH in ULC/MS grade water. Flow rate was set at 150 μL/min. Metabolites were identified based on exact mass within 5 ppm and further validated by concordance with retention times of standards. Metabolites were quantified using LCquan software (Thermo Scientific). Peak intensities were normalized based on median peak intensity.
RP-nanoLC-MS/MS
Proteomics data were acquired using an UHPLC 1290 system (Agilent) coupled to an Orbitrap Q Exactive Plus mass spectrometer (Thermo Scientific). Peptides were first trapped on a 2 cm x 100 μm Reprosil C18 pre-column (3 μm) and then separated on a 50 cm x 75 μm Poroshell EC-C18 analytical column (2.7 μm).
Trapping was performed for 10 min in 0.1M acetic acid (Solvent A) and elution with 80% ACN in 0.1M acetic acid (Solvent B) in gradients as follows: 10-36% solvent B in 155 min, 36-100% in 3min and finally 100% for 1min. Flow was passively split to 300 nl/min. MS data were obtained in data-dependent acquisition mode. Full scans were acquired in the m/z range of 375-1600 at the resolution of 35,000 (m/z 400) with AGC target 3E6.Top 15 most intense precursor ions were selected for HCD fragmentation performed at NCE 25% after accumulation to target value of 5E4. MS/MS acquisition was performed at a resolution of 17,500.
Database search
Raw files were processed using MaxQuant version 1.5.3.30 and searched against the human Swissprot database (version Jan 2016) using Andromeda. Cysteine carbamidomethylation was set to fixed modification, while variable modifications of methionine oxidation and protein N-terminal acetylation, as well as up to 2 missed cleavages were allowed. False discovery rate (FDR) was restricted to 1% in both protein and peptide identification. Label-free quantification (LFQ) was performed with "match between runs" enabled. One-way ANOVA tests were performed (* = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001). 
